A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.